The N-terminus of cMyBP-C can activate actomyosin interactions in the absence of Ca2+, but it is unclear which domains are necessary. Prior studies suggested that the Pro-Ala rich region of human cMyBP-C activated force in permeabilized human cardiomyocytes, whereas the C1 and M-domains of mouse cMyBP-C activated force in permeabilized rat cardiac trabeculae. Because the amino acid sequence of the P/A region differs between human and mouse cMyBP-C isoforms (46% identity), we investigated whether species-specific differences in the P/A region could account for differences in activating effects. Using chimeric fusion proteins containing combinations of human and mouse C0, Pro-Ala, and C1 domains, we demonstrate here that the human P/A and C1 domains activate actomyosin interactions, whereas the same regions of mouse cMyBP-C are less effective. These results suggest that species-specific differences between homologous cMyBP-C isoforms confer differential effects that could fine-tune cMyBP-C function in hearts of different species.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850553 | PMC |
| http://dx.doi.org/10.1155/2010/789798 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Early pathological mechanisms in a mouse model of heart failure with preserved ejection fraction.
Am J Physiol Heart Circ Physiol
December 2024
Department of Internal Medicine/Cardiology, Rush University Medical Center, Chicago, Illinois, United States.
Article Synopsis
- Heart failure with preserved ejection fraction (HFpEF) is a prevalent condition but lacks effective treatments, prompting a study to investigate its underlying causes using a mouse model exposed to a Western diet and excess mineralocorticoids.
- The study found early signs of cardiac issues such as diastolic dysfunction and left atrial enlargement within three weeks, even though heart ejection fraction remained normal.
- Molecular analysis revealed low-grade inflammation, oxidative stress, and impaired signaling pathways affecting heart stiffness and function, possibly linking dietary factors and mineralocorticoids to the progression of HFpEF.
Article Synopsis
- Cardiovascular disease is a major cause of death in the US, and environmental factors, like arsenic in drinking water, are linked to its development.
- This study investigates how arsenic exposure during pregnancy affects mothers’ heart health postpartum, revealing an increase in heart size and altered cellular functions in mice.
- The findings emphasize the need to reduce arsenic exposure during pregnancy and call for more research into its effects on maternal cardiovascular health and pregnancy outcomes.
The W792R HCM missense mutation in the C6 domain of cardiac myosin binding protein-C increases contractility in neonatal mouse myocardium.
J Mol Cell Cardiol
October 2024
Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, United States of America; UW Cardiovascular Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, United States of America. Electronic address:
Missense mutations in cardiac myosin binding protein C (cMyBP-C) are known to cause hypertrophic cardiomyopathy (HCM). The W792R mutation in the C6 domain of cMyBP-C causes severe, early onset HCM in humans, yet its impact on the function of cMyBP-C and the mechanism through which it causes disease remain unknown. To fully characterize the effect of the W792R mutation on cardiac morphology and function in vivo, we generated a murine knock-in model.
View Article and Find Full Text PDFRoles of cMyBP-C phosphorylation on cardiac contractile dysfunction in mice.
J Mol Cell Cardiol Plus
June 2024
Center for Cardiovascular Research, Department of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Type 2 diabetes mellitus (T2DM) is a metabolic disease and comorbidity associated with several conditions, including cardiac dysfunction leading to heart failure with preserved ejection fraction (HFpEF), in turn resulting in T2DM-induced cardiomyopathy (T2DM-CM). However, the molecular mechanisms underlying the development of T2DM-CM are poorly understood. It is hypothesized that molecular alterations in myopathic genes induced by diabetes promote the development of HFpEF, whereas cardiac myosin inhibitors can rescue the resultant T2DM-mediated cardiomyopathy.
View Article and Find Full Text PDFUnlabelled: During heart failure, gene and protein expression profiles undergo extensive compensatory and pathological remodeling. We previously observed that fast skeletal myosin binding protein-C (fMyBP-C) is upregulated in diseased mouse hearts. While fMyBP-C shares significant homology with its cardiac paralog, cardiac myosin binding protein-C (cMyBP-C), there are key differences that may affect cardiac function.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!